|
EP1849465A4
(en)
*
|
2005-02-18 |
2008-12-24 |
Takeda Pharmaceutical |
AGENS TO CONTROL THE FUNCTION OF THE GPR34 RECEPTOR
|
|
CA2662305C
(en)
|
2006-09-07 |
2012-04-17 |
Amgen Inc. |
Heterocyclic gpr40 modulators
|
|
EP2061760A1
(en)
*
|
2006-09-07 |
2009-05-27 |
Amgen, Inc |
Benzo-fused compounds for use in treating metabolic disorders
|
|
ES2446419T3
(es)
*
|
2007-04-16 |
2014-03-07 |
Amgen, Inc |
Moduladores de GPR40 de ácidos bifenilfenoxi, tiofenil y aminofenilpropanoico sustituidos
|
|
EP2025674A1
(de)
|
2007-08-15 |
2009-02-18 |
sanofi-aventis |
Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
JP5591706B2
(ja)
|
2007-10-10 |
2014-09-17 |
アムジエン・インコーポレーテツド |
置換ビフェニルｇｐｒ４０調節因子
|
|
AU2008319418B2
(en)
*
|
2007-10-29 |
2013-08-15 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
WO2009111056A1
(en)
*
|
2008-03-06 |
2009-09-11 |
Amgen Inc. |
Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders
|
|
CN104311472B9
(zh)
|
2008-07-23 |
2020-03-17 |
艾尼纳制药公司 |
经取代的1,2,3,4-四氢环戊并[b]吲哚-3-基乙酸衍生物
|
|
JP2012503595A
(ja)
*
|
2008-07-28 |
2012-02-09 |
シダンスク ユニバーシティ |
代謝病の治療用の化合物
|
|
PL2342205T4
(pl)
*
|
2008-08-27 |
2016-12-30 |
|
Podstawione tricykliczne pochodne kwasowe jako antagoniści receptora S1P1 użyteczni w leczeniu zaburzeń autoimmunologicznych i zapalnych
|
|
AU2009303475B2
(en)
*
|
2008-10-15 |
2012-09-13 |
Amgen Inc. |
Spirocyclic GPR40 modulators
|
|
EA022417B1
(ru)
*
|
2008-10-21 |
2015-12-30 |
Саймабэй Терапевтикс, Инк. |
Арильные агонисты рецептора gpr120 и их применение
|
|
AR074760A1
(es)
*
|
2008-12-18 |
2011-02-09 |
Metabolex Inc |
Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
|
|
EP2389226B1
(en)
*
|
2009-01-23 |
2013-11-20 |
Merck Sharp & Dohme Corp. |
Bridged and fused heterocyclic antidiabetic compounds
|
|
KR20120022801A
(ko)
*
|
2009-04-22 |
2012-03-12 |
아스텔라스세이야쿠 가부시키가이샤 |
카르복실산 화합물
|
|
EP2528894A1
(en)
|
2010-01-27 |
2012-12-05 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
|
|
CN105503882B
(zh)
|
2010-03-03 |
2019-07-05 |
艾尼纳制药公司 |
制备s1p1受体调节剂及其晶体形式的方法
|
|
WO2011107494A1
(de)
|
2010-03-03 |
2011-09-09 |
Sanofi |
Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
ES2526124T3
(es)
*
|
2010-06-16 |
2015-01-07 |
Cymabay Therapeutics, Inc. |
Agonistas del receptor GPR120 y sus usos
|
|
EP2582709B1
(de)
|
2010-06-18 |
2018-01-24 |
Sanofi |
Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
TW201215387A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Aventis |
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
|
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
|
EP2766349B1
(de)
|
2011-03-08 |
2016-06-01 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
WO2012120056A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2683704B1
(de)
|
2011-03-08 |
2014-12-17 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2012120054A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2012120055A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2511273B8
(en)
*
|
2011-04-15 |
2019-06-26 |
Hivih |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
WO2013037390A1
(en)
|
2011-09-12 |
2013-03-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
EP2760862B1
(en)
|
2011-09-27 |
2015-10-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
EP2803664B1
(en)
*
|
2012-01-12 |
2018-11-21 |
Jiangsu Hengrui Medicine Co. Ltd. |
Tetrahydrobenzofurane derivatives as gpr40 agonists for the treatment of diabetes
|
|
SG11201406759YA
(en)
|
2012-04-26 |
2014-11-27 |
Bristol Myers Squibb Co |
Imidazothiadiazole derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
|
|
KR20150003766A
(ko)
|
2012-04-26 |
2015-01-09 |
브리스톨-마이어스 스큅 컴퍼니 |
혈소판 응집을 치료하기 위한 프로테아제 활성화 수용체 4 (par4) 억제제로서의 이미다조티아디아졸 및 이미다조피리다진 유도체
|
|
ES2640916T3
(es)
|
2012-04-26 |
2017-11-07 |
Bristol-Myers Squibb Company |
Derivados de imidazotiadiazol e imidazopirazina como inhibidores del receptor 4 activados por proteasa (PAR4) para tratar agregación plaquetaria
|
|
US20140045746A1
(en)
|
2012-08-02 |
2014-02-13 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
CN105142621A
(zh)
|
2012-10-24 |
2015-12-09 |
国家健康科学研究所 |
用于预防或治疗糖尿病和促进β-细胞存活的TPL2激酶抑制剂
|
|
UY35143A
(es)
|
2012-11-16 |
2014-05-30 |
Bristol Myers Squibb Co |
Derivados de dihidropirazol como moduladores del receptor acoplado a la proteína gpr40 g
|
|
JP6314335B2
(ja)
*
|
2013-02-06 |
2018-04-25 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新しいインダニルオキシジヒドロベンゾフラニル酢酸
|
|
JP2016516004A
(ja)
|
2013-02-22 |
2016-06-02 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
抗糖尿病二環式化合物
|
|
AU2014221489B2
(en)
*
|
2013-02-28 |
2018-03-08 |
Tiumbio Co., Ltd. |
Tricyclic compound and use thereof
|
|
CN104109115B
(zh)
*
|
2013-04-16 |
2016-11-23 |
中国科学院上海药物研究所 |
一种含氮杂环链接的苯丙酸类化合物、其药物组合物、制备方法和用途
|
|
EP2821104A1
(en)
|
2013-07-05 |
2015-01-07 |
Laboratoire Biodim |
Inhibitors of viral replication, their process of preparation and their therapeutical uses
|
|
WO2015032328A1
(zh)
*
|
2013-09-03 |
2015-03-12 |
四川海思科制药有限公司 |
茚满衍生物及其制备方法和在医药上的应用
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
US10519115B2
(en)
|
2013-11-15 |
2019-12-31 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
WO2015084692A1
(en)
|
2013-12-04 |
2015-06-11 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
|
WO2015089809A1
(en)
|
2013-12-19 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Antidiabetic substituted heteroaryl compounds
|
|
US10059667B2
(en)
|
2014-02-06 |
2018-08-28 |
Merck Sharp & Dohme Corp. |
Antidiabetic compounds
|
|
WO2015176267A1
(en)
|
2014-05-22 |
2015-11-26 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
WO2016022448A1
(en)
|
2014-08-08 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
|
WO2016019587A1
(en)
|
2014-08-08 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
[7, 6]-fused bicyclic antidiabetic compounds
|
|
WO2016022742A1
(en)
|
2014-08-08 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
|
US10100042B2
(en)
|
2014-08-08 |
2018-10-16 |
Merck Sharp & Dohme Corp. |
[5,6]—fused bicyclic antidiabetic compounds
|
|
CA3002540C
(en)
|
2015-01-06 |
2023-11-07 |
Arena Pharmaceuticals, Inc. |
Use of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid for treating conditions related to the s1p1 receptor
|
|
EP3273981B1
(en)
|
2015-03-24 |
2020-04-29 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Method and pharmaceutical composition for use in the treatment of diabetes
|
|
JP6838744B2
(ja)
|
2015-06-22 |
2021-03-03 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
Ｓ１Ｐ１レセプター関連障害における使用のための（Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸（化合物１）の結晶性Ｌ−アルギニン塩
|
|
MA43313B1
(fr)
|
2015-09-02 |
2022-06-30 |
Trevena Inc |
Aza-hétérocyclique à 6 éléments contenant des composés modulateurs de récepteurs opioïdes delta, et leurs procédés de fabrication et d'utilisation
|
|
EP3436003B1
(en)
|
2016-03-29 |
2023-08-23 |
Merck Sharp & Dohme LLC |
Antidiabetic bicyclic compounds
|
|
US10882833B2
(en)
|
2016-05-23 |
2021-01-05 |
Institute Of Materia Medica, Chinese Academy Of Medical Sciences |
Phenylate derivative, preparation method therefor, and pharmaceutical composition and uses thereof
|
|
WO2018106518A1
(en)
|
2016-12-06 |
2018-06-14 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
|
WO2018118670A1
(en)
|
2016-12-20 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Antidiabetic spirochroman compounds
|
|
KR20190113955A
(ko)
|
2017-02-16 |
2019-10-08 |
아레나 파마슈티칼스, 인크. |
장-외 증상을 갖는 염증성 장질환의 치료를 위한 화합물 및 방법
|
|
CN110520124A
(zh)
|
2017-02-16 |
2019-11-29 |
艾尼纳制药公司 |
用于治疗原发性胆汁性胆管炎的化合物和方法
|
|
CN110520129A
(zh)
|
2017-02-17 |
2019-11-29 |
特维娜有限公司 |
含有5元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法
|
|
CN110446495B
(zh)
|
2017-02-17 |
2023-09-05 |
特维娜有限公司 |
含有7元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法
|
|
AR111199A1
(es)
|
2017-03-31 |
2019-06-12 |
Takeda Pharmaceuticals Co |
Compuesto aromático agonista de gpr40
|
|
BR102018007822A2
(pt)
|
2017-04-20 |
2018-11-06 |
Gilead Sciences, Inc. |
composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição
|
|
CN109320483A
(zh)
*
|
2017-08-01 |
2019-02-12 |
南京大学 |
香豆素衍生物、其制备方法及其作为药物的用途
|
|
RU2764243C2
(ru)
|
2017-09-22 |
2022-01-14 |
ДЖУБИЛАНТ ЭПИПЭД ЭлЭлСи |
Гетероциклические соединения в качестве ингибиторов PAD
|
|
CN111225915B
(zh)
|
2017-10-18 |
2023-03-07 |
朱比兰特埃皮帕德有限公司 |
作为pad抑制剂的咪唑并吡啶化合物
|
|
US11629135B2
(en)
|
2017-11-06 |
2023-04-18 |
Jubilant Prodell Llc |
Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation
|
|
US11225471B2
(en)
|
2017-11-16 |
2022-01-18 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
|
RS65576B1
(sr)
|
2017-11-24 |
2024-06-28 |
Jubilant Episcribe Llc |
Heterociklična jedinjenja kao inhibitori prmt5
|
|
WO2019160882A1
(en)
|
2018-02-13 |
2019-08-22 |
Gilead Sciences, Inc. |
Pd-1/pd-l1 inhibitors
|
|
CN112105610B
(zh)
|
2018-03-13 |
2024-01-26 |
朱比连特普罗德尔有限责任公司 |
作为pd1/pd-l1相互作用/活化的抑制剂的双环化合物
|
|
KR102591947B1
(ko)
|
2018-04-19 |
2023-10-25 |
길리애드 사이언시즈, 인코포레이티드 |
Pd-1/pd-l1 억제제
|
|
JP7397011B2
(ja)
|
2018-06-06 |
2023-12-12 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
Ｓ１ｐ１受容体に関連する状態を治療する方法
|
|
PE20210642A1
(es)
|
2018-07-13 |
2021-03-23 |
Gilead Sciences Inc |
Inhibidores de pd-1/pd-l1
|
|
EP3847158B1
(en)
|
2018-09-06 |
2026-06-24 |
Arena Pharmaceuticals, Inc. |
Compounds useful in the treatment of autoimmune and inflammatory disorders
|
|
US11236085B2
(en)
|
2018-10-24 |
2022-02-01 |
Gilead Sciences, Inc. |
PD-1/PD-L1 inhibitors
|
|
WO2020114475A1
(zh)
*
|
2018-12-06 |
2020-06-11 |
上海济煜医药科技有限公司 |
作为免疫调节的芳环衍生物及其制备方法和应用
|
|
CN110156761B
(zh)
*
|
2019-06-18 |
2022-08-09 |
郑州大学 |
含香豆素-联苯骨架化合物、制备方法及其应用
|
|
US12486229B2
(en)
|
2020-07-03 |
2025-12-02 |
Shanghai Medicilon Inc. |
Indole derivative and application thereof
|
|
CN114163426B
(zh)
|
2020-09-10 |
2024-03-19 |
上海爱博医药科技有限公司 |
苯并含氧杂环类化合物及其医药应用
|
|
CN116406268A
(zh)
|
2020-10-27 |
2023-07-07 |
特维娜有限公司 |
δ-阿片样物质调节剂的结晶和无定形形式
|
|
CN115340484A
(zh)
*
|
2021-05-13 |
2022-11-15 |
上海美迪西生物医药股份有限公司 |
苄氧基吲哚类支链酸类衍生物及其制备方法和应用
|
|
JP7873907B2
(ja)
*
|
2022-11-22 |
2026-06-15 |
西安新通薬物研究股▲フン▼有限公司 |
新規二環系ｐｄ－ｌ１阻害剤、その製造方法、及び医薬使用
|
|
CN116283560B
(zh)
*
|
2023-02-27 |
2026-06-26 |
南通大学 |
一种基于水溶性柱芳烃的纳米诊疗材料
|
|
WO2025141118A1
(en)
*
|
2023-12-27 |
2025-07-03 |
Institut National de la Santé et de la Recherche Médicale |
Arylalkyloxyindole compounds and derivatives and their use
|